Kukje Pharma Co., Ltd.
シンボルマーク: 002720.KS
KSC
4940
KRW今日の市場価格
-11.8884
PER（株価収益率
-0.1069
PEGレシオ
100.04B
MRK キャップ
- 0.00%
DIV利回り
Kukje Pharma Co., Ltd. (002720-KS) 財務諸表
貸借対照表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 41530.25 | 10632.2 | 5559.1 | 7903 | |||||||||||||||||
balance-sheet.row.short-term-investments | 122.85 | 42.3 | 20.2 | 36.9 | |||||||||||||||||
balance-sheet.row.net-receivables | 87640.04 | 22141.3 | 20741.2 | 23753.9 | |||||||||||||||||
balance-sheet.row.inventory | 86355.78 | 21243.1 | 22235.2 | 16540.4 | |||||||||||||||||
balance-sheet.row.other-current-assets | 2335 | 2335 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-current-assets | 217861.08 | 56351.6 | 48535.5 | 48197.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 329892.77 | 99124 | 78379.8 | 81980.9 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 3942.6 | 919.3 | 1125.4 | 1333.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3942.6 | 919.3 | 1125.4 | 1333.3 | |||||||||||||||||
balance-sheet.row.long-term-investments | 18994.8 | 7199.4 | 3963.4 | 3915.7 | |||||||||||||||||
balance-sheet.row.tax-assets | 10766.12 | 6128.1 | 6961.3 | 4355.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 9463.88 | 897.6 | -2372.5 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 373060.16 | 114268.3 | 88057.4 | 91585.7 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 590921.24 | 170619.9 | 136592.9 | 139783 | |||||||||||||||||
balance-sheet.row.account-payables | 32633.62 | 8564 | 7068.4 | 7249 | |||||||||||||||||
balance-sheet.row.short-term-debt | 118212 | 30186.3 | 27399.9 | 34366.4 | |||||||||||||||||
balance-sheet.row.tax-payables | 7944.12 | 1582.5 | 1487.9 | 302.5 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 3837.24 | 475.7 | 1196.1 | 1620.3 | |||||||||||||||||
Deferred Revenue Non Current | 1259.56 | 352.9 | 296.9 | 7810.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 44294.01 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 29280.16 | 19231.6 | 10360.7 | 46.2 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 71241.38 | 25966.4 | 14658.5 | 16678.6 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4862.9 | 475.7 | 1596 | 1986.6 | |||||||||||||||||
balance-sheet.row.total-liab | 296436.17 | 85670.4 | 62513.6 | 71195.2 | |||||||||||||||||
balance-sheet.row.preferred-stock | 47055.35 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 83674.65 | 21159.8 | 20195.1 | 19276.1 | |||||||||||||||||
balance-sheet.row.retained-earnings | -2236.25 | -8381 | 6327 | 1094.5 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 140979.6 | 72637.1 | 47028 | 48633.8 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 24989.47 | -471.8 | 523.9 | -436.4 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 294462.81 | 84944.1 | 74074.1 | 68568.1 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 590915.08 | 170619.9 | 136592.9 | 139783 | |||||||||||||||||
balance-sheet.row.minority-interest | 22.26 | 5.5 | 5.2 | 19.7 | |||||||||||||||||
balance-sheet.row.total-equity | 294485.07 | 84949.6 | 74079.3 | 68587.8 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 590915.08 | - | - | - | |||||||||||||||||
Total Investments | 19117.65 | 7241.7 | 3983.6 | 3952.6 | |||||||||||||||||
balance-sheet.row.total-debt | 122049.25 | 30662.1 | 28596 | 35986.6 | |||||||||||||||||
balance-sheet.row.net-debt | 80641.85 | 20072.2 | 23057.1 | 28120.6 |
キャッシュフロー計算書
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -8414.22 | -8415.2 | 3542.8 | -1555.8 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 4204.13 | 4204.1 | 4488 | 4419 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 5428.79 | 5428.8 | -4274.2 | 5597.3 | |||||||||||||||||
cash-flows.row.account-receivables | 565.75 | 565.8 | 4648.4 | 4595.1 | |||||||||||||||||
cash-flows.row.inventory | 1289.7 | 1289.7 | -4789.1 | 3261.1 | |||||||||||||||||
cash-flows.row.account-payables | 11579.3 | 11579.3 | 711.1 | 933.2 | |||||||||||||||||
cash-flows.row.other-working-capital | -8005.96 | -8006 | -4844.7 | -3192 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 2356.48 | 2357.4 | 2747.3 | 1136.6 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 3575.18 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1045.9 | -1045.9 | -1276.8 | -1960.6 | |||||||||||||||||
cash-flows.row.acquisitions-net | 35.74 | 35.7 | 81.4 | -45.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -50 | -50 | 0 | -1462.2 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 510 | 510 | 0 | 100.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | -624.89 | -624.9 | -151.5 | -14.6 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -1175.05 | -1175.1 | -1346.9 | -3381.8 | |||||||||||||||||
cash-flows.row.debt-repayment | -7900 | -3000 | -7000 | -2000 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -31.07 | -31.1 | -40.6 | -45.5 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 10692.44 | 5641.1 | -433 | -388.4 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 2609.99 | 2610 | -7473.6 | -2433.9 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 40.82 | 40.8 | -10.4 | 71.7 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 5050.94 | 5050.9 | -2327.1 | 3853 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 41407.4 | 10589.9 | 5538.9 | 7866.1 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 36356.46 | 5538.9 | 7866.1 | 4013 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 3575.18 | 3575.2 | 6503.8 | 9597.1 | |||||||||||||||||
cash-flows.row.capital-expenditure | -1045.9 | -1045.9 | -1276.8 | -1960.6 | |||||||||||||||||
cash-flows.row.free-cash-flow | 2529.29 | 2529.3 | 5227 | 7636.5 |
損益計算書の行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 135372.69 | 135372.7 | 126583.4 | 119745.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 68290.41 | 68907.7 | 63329.3 | 65275.3 | |||||||||||||||||
income-statement-row.row.gross-profit | 67082.28 | 66465 | 63254.1 | 54470.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 2506.56 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 39427.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 36229.06 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -33387.44 | -2249.3 | 28438.4 | 27046.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 31258.31 | 68454.1 | 57981.6 | 56146.2 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 101671.11 | 137361.8 | 121310.9 | 121421.5 | |||||||||||||||||
income-statement-row.row.interest-income | 394.02 | 394 | 230.9 | 114.3 | |||||||||||||||||
income-statement-row.row.interest-expense | 1439.89 | 1439.9 | 1000.5 | 696.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 36229.06 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -4691.47 | -4691.5 | -527.4 | -709 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -33387.44 | -2249.3 | 28438.4 | 27046.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -4691.47 | -4691.5 | -527.4 | -709 | |||||||||||||||||
income-statement-row.row.interest-expense | 1439.89 | 1439.9 | 1000.5 | 696.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 22365.8 | 4204.1 | 5487.9 | 4419 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 36063.55 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -1989.14 | -1989.1 | 5272.5 | -401.3 | |||||||||||||||||
income-statement-row.row.income-before-tax | -6680.61 | -6680.6 | 4745.1 | -1110.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 1734.28 | 1734.3 | 1202.3 | 445.5 | |||||||||||||||||
income-statement-row.row.net-income | -8415.19 | -8415.2 | 3557.3 | -1555.8 |
よくある質問
Kukje Pharma Co., Ltd.002720.KS 総資産とは何ですか？
Kukje Pharma Co., Ltd. (002720.KS) 総資産は 170619924207.000.
企業の年間売上高とは？
年間収益は 67420082316.000である.
企業の利益率は？
利益率は 0.496 である.
企業のフリーキャッシュフローとは？
フリーキャッシュフローは 124.893.
企業の純利益率は？
純利益率は -0.062 である.
企業の総収入は？
総収入は -0.015 である.
Kukje Pharma Co., Ltd. (002720.KS) 純利益（純利益）とは何ですか？
純利益（純利益）は -8415187456.000.
負債総額は？
負債合計は 30662085312.000 である.
営業費用はいくらですか？
営業費用は 68454126265.000 である.
会社の現金はいくらですか？
企業の現金は 10589867418.000 である.